Literature DB >> 23649333

Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice.

Tamaki Watanabe1, Naoko H Tomioka, Masaru Doshi, Shigekazu Watanabe, Masao Tsuchiya, Makoto Hosoyamada.   

Abstract

Preventing the onset of microalbuminuria in diabetic nephropathy is a problem that needs urgent rectification. The use of a mouse model for diabetes is vital in this regard. For example, db/db mice exhibit defects in the leptin receptor Ob-Rb sub-type, while the ob/ob strain exhibits defects in the leptin ligand. These mouse strains demonstrate type 2 diabetes, either with or without microalbuminuria, respectively. The purpose of the present study was to use DNA microarray technology to screen for the gene responsible for the onset of diabetic microalbuminuria. Using Affymetrix Mouse Gene ST 1.0 arrays, microarray analysis was performed using total RNA from the kidneys of ob control, ob/ob, db/m, and db/db mice. Microarray and quantitative reverse transcription-polymerase chain reaction (RT-PCR) indicated that transcription of the macrophage migration inhibitory factor (MIF) gene was significantly enhanced in the kidneys of db/db mice. Western blotting showed that levels of MIF protein was enhanced in the kidneys of both diabetic db/db and ob/ob mice. On the other hand, elevation of urinary MIF excretion detected by enzyme-linked immunosorbent assay (ELISA) was only in db/db mice and preceded the onset of microalbuminuria. Immunofluorescence studies revealed that MIF was expressed in mouse kidney glomeruli. While MIF expression was enhanced in the diabetic kidneys of both mouse strains, the elevated secretion from db/db mouse kidneys may be responsible for initiating the onset of microalbuminuria in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649333     DOI: 10.1248/bpb.b12-00741

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.

Authors:  Zhigang Wang; Meng Wei; Meng Wang; Lei Chen; Hua Liu; Yi Ren; Kehui Shi; Hongli Jiang
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 2.  Role of the Immune System in Diabetic Kidney Disease.

Authors:  Fionnuala B Hickey; Finian Martin
Journal:  Curr Diab Rep       Date:  2018-03-12       Impact factor: 4.810

3.  EDA2R mediates podocyte injury in high glucose milieu.

Authors:  Xiqian Lan; Vinod Kumar; Alok Jha; Rukhsana Aslam; Haichao Wang; Kehong Chen; Yueming Yu; Weimei He; Feilan Chen; Huairong Luo; Ashwani Malhotra; Pravin C Singhal
Journal:  Biochimie       Date:  2020-04-15       Impact factor: 4.079

Review 4.  Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.

Authors:  Annette Bruchfeld; Mårten Wendt; Edmund J Miller
Journal:  Front Immunol       Date:  2016-01-26       Impact factor: 7.561

5.  Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice.

Authors:  Haojun Zhang; Tingting Zhao; Zhiguo Li; Meihua Yan; Hailing Zhao; Bin Zhu; Ping Li
Journal:  J Diabetes Res       Date:  2017-01-23       Impact factor: 4.011

6.  Macrophage migration inhibitory factor antagonist (p425) ameliorates kidney histopathological and functional changes in diabetic rats.

Authors:  Jamal Khalilpour; Shiva Roshan-Milani; Farzaneh Hosseini Gharalari; Amin Abdollahzade Fard
Journal:  J Bras Nefrol       Date:  2019-01-24

Review 7.  Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases.

Authors:  Zhensheng Cai; Xia Deng; Jue Jia; Dong Wang; Guoyue Yuan
Journal:  Front Physiol       Date:  2021-12-06       Impact factor: 4.566

8.  Regulation of Podocyte Injury by CircHIPK3/FUS Complex in Diabetic Kidney Disease.

Authors:  Feng Liu; Jing Huang; Chunyun Zhang; Yaru Xie; Yiling Cao; Li Tao; Hui Tang; Jihong Lin; Hans-Peter Hammes; Kun Huang; Fan Yi; Hua Su; Chun Zhang
Journal:  Int J Biol Sci       Date:  2022-09-01       Impact factor: 10.750

Review 9.  The role of MIF in type 1 and type 2 diabetes mellitus.

Authors:  Yuriko I Sánchez-Zamora; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2014-01-02       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.